Reify Health Raises $220 Million to Eliminate Waiting in Clinical Trials

The company, through its business entities StudyTeam and Care Access, is making clinical trials fast and predictable by radically expanding patient access
BOSTON, August 10, 2021 –( BUSINESS WIRE )– Reify Health today announced a $220 million Series C funding round led by Coatue Management, joined by ICONIQ Growth and Adams Street Partners, as well as existing investors Sierra Ventures and Battery Ventures.

Read the source article at sg.finance.yahoo.com
2021-08-10 14:00:00